OCULAR THERAPEUTIX, INC

For the period ended Jun 11, 2026. Filed Apr 30, 2026.

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 11, 2026 · Filed Apr 30, 2026

Use the contents to explore the available documents and sections.

OCUL$6.60+2.6%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

Appendix A

AMENDMENT NO. 5 TO 2021 STOCK INCENTIVE PLAN

WHEREAS, Ocular Therapeutix, Inc. (the “Company”) maintains the 2021 Stock Incentive Plan, as amended (the “Plan”);

WHEREAS, the Board of Directors of the Company has determined that it is in the best interest of the Company and its stockholders to amend the Plan, pursuant to Section 11(d) thereof, to increase the number of shares of Company common stock that may be granted under the Plan;

NOW, THEREFORE, in consideration of the foregoing, the Plan is amended, pursuant to Section 11(d) thereof, as follows:

1.	The number set forth in Section 4(a)(1)(A) of the Plan is increased by 10,000,000 shares of Common Stock to 39,250,000 shares of Common Stock.

Except as set forth above, all other terms of the Plan shall remain unchanged and in full force and effect.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.